Arcutis Biotherapeutics Stock Market Value
| ARQT Stock | USD 10.77 0.63 6.21% |
| Symbol | Arcutis |
Arcutis Biotherapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcutis Biotherapeutics. If investors know Arcutis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcutis Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.77) | Revenue Per Share 1.228 | Quarterly Revenue Growth 0.174 | Return On Assets (0.31) | Return On Equity (1.92) |
The market value of Arcutis Biotherapeutics is measured differently than its book value, which is the value of Arcutis that is recorded on the company's balance sheet. Investors also form their own opinion of Arcutis Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Arcutis Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcutis Biotherapeutics' market value can be influenced by many factors that don't directly affect Arcutis Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcutis Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcutis Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcutis Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Arcutis Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arcutis Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arcutis Biotherapeutics.
| 05/30/2024 |
| 11/26/2024 |
If you would invest 0.00 in Arcutis Biotherapeutics on May 30, 2024 and sell it all today you would earn a total of 0.00 from holding Arcutis Biotherapeutics or generate 0.0% return on investment in Arcutis Biotherapeutics over 180 days. Arcutis Biotherapeutics is related to or competes with Terns Pharmaceuticals, Amylyx Pharmaceuticals, Acumen Pharmaceuticals, Inozyme Pharma, X4 Pharmaceuticals, Mirum Pharmaceuticals, and Day One. Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for der... More
Arcutis Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arcutis Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arcutis Biotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.61 | |||
| Information Ratio | 0.0202 | |||
| Maximum Drawdown | 15.74 | |||
| Value At Risk | (5.44) | |||
| Potential Upside | 7.0 |
Arcutis Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arcutis Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arcutis Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Arcutis Biotherapeutics historical prices to predict the future Arcutis Biotherapeutics' volatility.| Risk Adjusted Performance | 0.051 | |||
| Jensen Alpha | (0) | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0198 | |||
| Treynor Ratio | 0.1156 |
Arcutis Biotherapeutics Backtested Returns
Currently, Arcutis Biotherapeutics is not too volatile. Arcutis Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.0204, which signifies that the company had a 0.0204% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Arcutis Biotherapeutics, which you can use to evaluate the volatility of the firm. Please confirm Arcutis Biotherapeutics' risk adjusted performance of 0.051, and Mean Deviation of 2.64 to double-check if the risk estimate we provide is consistent with the expected return of 0.0707%. Arcutis Biotherapeutics has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.64, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Arcutis Biotherapeutics will likely underperform. Arcutis Biotherapeutics right now shows a risk of 3.46%. Please confirm Arcutis Biotherapeutics value at risk, and the relationship between the standard deviation and kurtosis , to decide if Arcutis Biotherapeutics will be following its price patterns.
Auto-correlation | -0.35 |
Poor reverse predictability
Arcutis Biotherapeutics has poor reverse predictability. Overlapping area represents the amount of predictability between Arcutis Biotherapeutics time series from 30th of May 2024 to 28th of August 2024 and 28th of August 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arcutis Biotherapeutics price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current Arcutis Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.35 | |
| Spearman Rank Test | 0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.6 |
Arcutis Biotherapeutics lagged returns against current returns
Autocorrelation, which is Arcutis Biotherapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Arcutis Biotherapeutics' stock expected returns. We can calculate the autocorrelation of Arcutis Biotherapeutics returns to help us make a trade decision. For example, suppose you find that Arcutis Biotherapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Arcutis Biotherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Arcutis Biotherapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Arcutis Biotherapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Arcutis Biotherapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Arcutis Biotherapeutics Lagged Returns
When evaluating Arcutis Biotherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Arcutis Biotherapeutics stock have on its future price. Arcutis Biotherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Arcutis Biotherapeutics autocorrelation shows the relationship between Arcutis Biotherapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Arcutis Biotherapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arcutis Stock Analysis
When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.